AstraZeneca Denied Attys' Fees Despite Crestor Patent Win
AstraZeneca Pharmaceuticals LP can't get attorneys' fees from Teva Pharmaceutical Industries Ltd. despite winning a patent fight over AstraZeneca's blockbuster cholesterol drug Crestor, a Pennsylvania federal judge ruled Thursday, saying AstraZeneca...To view the full article, register now.
Already a subscriber? Click here to view full article